EP3572091
Breytt relaxín fjölpeptíð og notkun á þeim
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.8.2011EP published:
13.12.2023EP application number:
19170008.7
EP translation filed:
4.3.2024Grant published:
15.4.2024EPO information:
European Patent Register
Max expiry date:
16.8.2031Expiry date:
16.8.2025
Title in English:
MODIFIED RELAXIN POLYPEPTIDES AND THEIR USESLanguage of the patent:
English
Timeline
Today
17.8.2011EP application
13.12.2023EP Publication
4.3.2024Translation submitted
15.4.2024Registration published
16.8.2025Expires
Owner
Name:
Ambrx, Inc.Address:
10975 North Torrey Pines Road, Suite 100, La Jolla CA 92037, US
Inventor
Name:
KARYNOV, VadimAddress:
San Diego, CA 92130, US
Name:
KNUDSEN, NickAddress:
San Diego, CA 92127, US
Name:
HEWET, AmhaAddress:
San Diego, CA 92116, US
Name:
DE DIOS, KristineAddress:
San Diego, CA 92126, US
Name:
PINKSTAFF, JasonAddress:
Carlsbad, CA 92009, US
Name:
SULLIVAN, LorraineAddress:
San Diego, CA 92117, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
37458210 PDate:
17.8.2010Country:
US
Classification
Categories:
A61K 38/22, C07K 14/64, C07K 17/08, C07H 21/04, C07K 1/04, C12N 1/19, C12P 21/02, C12N 1/21, A61P 9/00, A61P 9/10, A61P 31/00, A61P 17/02, A61P 25/28, A61K 47/60
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 9.7.2024
Expires: 16.8.2025
Payer: Árnason Faktor ehf.